Clinical Trials
3 trialsNCT01115803 2019-02-05
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
NCT01394003 2019-01-18
A Study of LY2584702 in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Terminated
NCT01241461 2018-08-21
A Study of LY2584702 in Solid Tumors
Eli Lilly and Company
Phase 1 Completed